Subscribe to our Newsletters !!
There is one fact about life on Earth we cannot es
In biological research, especially in areas such a
The Nobel Prize in Physiology or Medicine awarded
In today’s rapidly evolving bioprocessing landsc
By the end of 2025, the pharma, laboratory, and an
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of The Magazine
Seegene Inc Seol Korea based company used newly created artificial intelligence (AI)-based assay development system to develop two multiplexed molecular diagnostics for meningitis and Sexually transmitted Diseases.
The assays are based on Allplex real-time polymerase chain reaction (PCR) reagents designed to detect eight different DNA targets simultaneously.
The Seegene digitized development system automates real-time PCR assay development, driving down the cost of molecular diagnostic tests and enabling nonprofessionals to develop multiplexed assays.
The company’s pipeline of products includes assays that diagnose not only infectious diseases but also drug-resistant pathogens, genetic disorders, and various cancers, including breast, colon, and lung cancers.
For more information
